Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
44.15
+1.61 (+3.78%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
July 10, 2024
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low.
Via
Benzinga
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
July 09, 2024
A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher.
Via
InvestorPlace
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
July 08, 2024
Pfizer's RSV vaccine, Abrysvo, for pregnant women shows no increased risk of pre-term births, according to a study. Researchers found no significant difference in pre-term birth rates between...
Via
Benzinga
United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win
July 05, 2024
New leadership in the United Kingdom could make several sectors standout going forward. Here's what experts are saying after the election.
Via
Benzinga
Topics
ETFs
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.
Via
InvestorPlace
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
July 03, 2024
CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
July 03, 2024
CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK.
Via
InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...
Via
Benzinga
Exposures
COVID-19
3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
July 03, 2024
A modest amount of money can go a long way when it's put to work in highly innovative, game-changing businesses.
Via
The Motley Fool
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
July 02, 2024
A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
June 27, 2024
The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further...
Via
Benzinga
Why Is Moderna Stock Trading Lower On Wednesday?
June 26, 2024
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in...
Via
Benzinga
Exposures
COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
June 26, 2024
After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease.
Via
Investor's Business Daily
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.
Via
Benzinga
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
June 24, 2024
Pfizer secures a UK contract to supply millions of doses of its Abrysvo RSV vaccine, surpassing GSK's bid. The agreement includes doses for older adults and pregnant mothers.
Via
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
June 18, 2024
Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.
Via
Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year.
Via
InvestorPlace
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
If approved, this would be the first combination vaccine based on mRNA technology to hit the market.
Via
Investor's Business Daily
Exposures
COVID-19
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
June 07, 2024
From
GSK plc
Via
Business Wire
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
These undervalued pharma stocks to buy are worth a look because even when the economy is struggling, consumers need key medicines.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Large Cap BIopharmaceuticals Overview
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 03, 2024
Investors in GlaxoSmithKline are seeing a lot of red on their screens today, as GSK stock falls more than 8% on big legal news.
Via
InvestorPlace
Topics
Lawsuit
Exposures
Financial
Legal
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
June 03, 2024
GSK presented interim results from the DREAMM-8 phase 3 trial at ASCO 2024. Blenrep (belantamab mafodotin) with PomDex showed a significant improvement in progression-free survival for relapsed or...
Via
Benzinga
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
June 03, 2024
GSK shares fell as the Delaware State Court allowed over 70,000 lawsuits regarding the discontinued heartburn drug Zantac (ranitidine) to proceed. This ruling contradicts a Federal Court's 2022...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.